Latest Headlines

  1. Personalis Enables Global Biopharma Support With CE-IVD Marked Specimen Collection Kits 6/9/2026

    Personalis, Inc., a leader in advanced genomics for precision oncology, today announced that its Personalis EDTA Blood Collection Kit and Personalis cfDNA Blood Collection Kit have obtained Class A CE-IVD marking in compliance with the European Union’s In Vitro Diagnostic Regulation (IVDR).

  2. Scispot Raises $8M Series A To Help Life Sciences Labs Move Faster 6/4/2026

    Scispot, the Canadian company behind the AI-native operating layer for modern labs, today announced an $8 million USD Series A led by Avenue Growth Partners, a Washington, DC-based investment firm.

  3. Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio At ASM Microbe 2026 6/4/2026

    At ASM Microbe 2026, Bruker Corporation’s Microbiology & Infection Diagnostics (BMID) division is demonstrating its expanding portfolio and innovations across microbial identification, sepsis diagnostics, molecular testing, and NGS workflows, advancing clinical research, and faster, actionable infectious disease diagnostics.

  4. General Fluidics And Invetech Partner To Accelerate Accessible Diagnostics At The Point Of Care 6/4/2026

    General Fluidics (GF) and Invetech today announced a strategic collaboration to bring fast, high-quality diagnostics closer to patients, enabling earlier decisions, better outcomes, and broader access to care.

  5. Roche Rapidly Develops A PCR Test For Ebola Within Six Days As Rare Bundibugyo Virus Drives Urgent Need For Detection 6/4/2026

    Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that it developed a Research Use Only (RUO) molecular PCR test, via its subsidiary TIB MOLBIOL, for use on the LightCycler® 480 I & II Systems, LightCycler® PRO System and the cobas® z 480 analyzer to detect the rare Ebola Bundibugyo virus. Developed within just six days as part of its outbreak preparedness and surveillance expertise, this test supports response efforts in Central and East Africa and helps address critical needs identified during the ongoing outbreak.

  6. Distek Launches BIOne Core Software For Streamlined Bioprocess Data Management 6/3/2026

    Distek, Inc., a leading manufacturer of bioprocessing equipment, announces the release of their BIOne Core Software, an advanced, cloud-based historian software platform designed exclusively for BIOne Bioprocess Controllers.

  7. Cubis III: Compliant Weighing, Direct Integration, And Scalable Connectivity, Without Extra Software 6/3/2026

    Sartorius launches Cubis III, the latest innovation in its premium line of lab balances, delivering compliant, connected weighing without relying on extra software typically required to bridge instruments and lab systems.

  8. Sustainable Sample Management Without Disrupting Operations 6/3/2026

    Azenta Life Sciences has announced a collaboration with PulpFixin®, a pioneering manufacturer of sustainable labware, to help laboratories reduce plastic waste without sacrificing performance, traceability, or operational efficiency.

  9. Waters Announces FDA 510(k) Clearance Of BD BACTEC FXI Culture System, Enabling Broader Access To Bloodstream Infection Diagnostics 6/3/2026

    Waters Corporation (NYSE: WAT) today announced that the BD BACTEC FXI Culture System has received U.S. Food and Drug Administration (FDA) 510(k) clearance.

  10. Zepto Life Technology Receives FDA Breakthrough Device Designation For Targeted Liquid Biopsy Test For Invasive Mold Infections 6/3/2026

    Zepto Life Technology announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the FungiFlex® Mold Panel, a liquid biopsy test designed to aid in the diagnosis of invasive mold infections through detection and identification of fungal cell-free DNA directly from plasma.